KILL Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)

October 11, 2025 at 15:22 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Molecular Targeting Technologies, Inc. requests that their press release NewsItemId: 20251013226693 issued Oct 10, 2025 “Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)” be killed.

The release was issued prematurely by Molecular Targeting Technologies, Inc.

A replacement release will be reissued on Tuesday, Oct. 14th.

Contacts

Chris Pak, Email: cpak@mtarget.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	238.00	-6.19 (-2.53%)
AAPL	291.58	+1.03 (0.35%)
AMD	452.40	-23.11 (-4.86%)
BAC	54.54	+0.12 (0.22%)
GOOG	353.32	-8.97 (-2.48%)
META	570.98	-13.61 (-2.33%)
MSFT	397.36	-6.05 (-1.50%)
NVDA	200.42	-7.77 (-3.73%)
ORCL	201.26	-4.55 (-2.21%)
TSLA	381.59	-15.09 (-3.80%)

Symbol

Price

Change (%)

AMZN

238.00

-6.19 (-2.53%)

AAPL

291.58

+1.03 (0.35%)

AMD

452.40

-23.11 (-4.86%)

BAC

54.54

+0.12 (0.22%)

GOOG

353.32

-8.97 (-2.48%)

KILL Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)

Contacts

More News

Recent Quotes